As of my last update in October 2023, there is limited publicly available information regarding the chemical substance "YLIU-4-105-1" with the CAS number "2417685-83-5." This compound may be a research chemical or a proprietary substance, which often means that detailed characteristics such as its molecular structure, physical properties, and potential applications may not be widely documented in standard chemical databases. Typically, for novel compounds, characteristics such as solubility, melting and boiling points, reactivity, and safety data would be determined through experimental studies. If you are looking for specific information about this compound, including its synthesis, biological activity, or safety profile, it may be necessary to consult scientific literature, patent filings, or databases that specialize in chemical substances. Always ensure to handle any chemical with appropriate safety measures and consult material safety data sheets (MSDS) when available.

YLIU-4-105-1

2417685-83-5: As of my last update in October 2023, there is limited publicly available information regarding the chemical substance "YLIU-4-105-1" with the CAS number "2417685-83-5." This compound may be a research chemical or a proprietary substance, which often means that detailed characteristics such as its molecular structure, physical properties, and potential applications may not be widely documented in standard chemical databases. Typically, for novel compounds, characteristics such as solubility, melting and boiling points, reactivity, and safety data would be determined through experimental studies. If you are looking for specific information about this compound, including its synthesis, biological activity, or safety profile, it may be necessary to consult scientific literature, patent filings, or databases that specialize in chemical substances. Always ensure to handle any chemical with appropriate safety measures and consult material safety data sheets (MSDS) when available.

<p>YLIU-4-105-1 is a type II JAK2 inhibitor. Demonstrating in vivo pharmacological activity, YLIU-4-105-1 reduces splenic weight, decreases blood reticulocyte counts in a dose-dependent manner, and inhibits pSTAT5.</p>

CAS 2417685-83-5

YLIU-4-105-1

YLIU-4-105-1

Ref: TM-T201176